Bronchiectasis
Conditions
Interventions
Experimental Group: 70 individuals with bronchiectasis who will do physical exercises during 12 weeks, three times a week, 36 attendances in total with the appropriate medication. The protocol include
Other
G11.427.410.698.277
Q65.060
Sponsors
Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Eligibility
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients of both gender with clinical diagnosis of bronchiectasis, with moderate or severe according with the FACED score: age between 18 and 80 years, clinically stable (without hospitalizations or infections in the last three months of the study beginning).
Exclusion criteria
Exclusion criteria: Patients who presented other respiratory chronic disease associated that needed treatment or urgent intervention; other disabling diseases, severe or with difficult control; patients who did not finished the study protocol and/or those who presented exacerbations during the period of their participation in the research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant improvement of the inflammatory markers (fibrinogen, albumin, and PCR) after 12 weeks of the intervention protocol. ;Significant increase of the functional capacity from the increase of the walked distance in the six-minute walking test after 12 weeks of the intervention protocol. | — |
Secondary
| Measure | Time frame |
|---|---|
| Significant improvement in the quality of life using the quality of life questionnaires (SGRQ and LCQ) after 12 weeks of the intervention protocol. ;Significant decrease in the anxiety and depression score punctuation using the Beck Questionnaire of Anxiety and Depression after 12 weeks of the intervention protocol. ;Significant improvement of respiratory muscle strength using manovacuometry and the maximum strength of upper and lower limb using the one maximum repetition after 12 weeks of the intervention protocol. ;Significant improvement of fatigue and dyspnea using the fatigue severity scale and of the index of modified dyspnea (MMRC) after 12 weeks of the intervention protocol. | — |
Countries
Brazil
Contacts
Public ContactAmanda Araújo
Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Outcome results
None listed